Costs and Cost-effectiveness of Four Treatment Regimens for Latent Tuberculosis Infection
AUTOR(ES)
Holland, David P.
FONTE
American Thoracic Society
RESUMO
Rationale: Isoniazid given daily for 9 months is the standard treatment for latent tuberculosis infection (LTBI), but its effectiveness is limited by poor completion rates. Shorter course regimens and regimens using directly observed therapy result in improved adherence but have higher upfront costs.
